Drug · DIN 02244149
PROTOPIC
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 25, 2017; first marketed September 6, 2001.
- Drug Identification Number (DIN)
- 02244149
- Company (DIN owner)
- Leo Pharma IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Ointment
- Route
- Topical
- Therapeutic class (ATC)
- Tacrolimus D11AH01
- Class
- Human
- Record last updated
- May 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TACROLIMUS | 0.03 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 22, 2016: NOC 18198New Drug Submission (NDS) · Transfer of drug identification number
- April 12, 2005: NOC 6431New Drug Submission (NDS) · Manufacturer name change
- June 25, 2001: NOC 2636New Drug Submission (NDS)
Other DINs named PROTOPIC
- DIN 02244148 · Marketed